文献速递腹部技术与安全US

优化对比增强超声(CEUS)肝脏影像报告与数据系统(LI-RADS)用于非肝硬化乙型肝炎病毒感染患者肝细胞癌诊断:纳入甲胎蛋白或调整廓清标准

Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria.
PubMed 文献 · Clin Radiol · 2026-02-18

本研究回顾性纳入105例经病理确诊的非肝硬化乙型肝炎病毒(NC-HBV)感染患者的局灶性肝脏病变,比较原始CEUS LI-RADS(标准1)与三种改良标准(标准2:将AFP>200 ng/mL的LR-M结节重新分类为LR-5;标准3:AFP>400 ng/mL重新分类为LR-5;标准4:将LR-M的早期廓清阈值从60秒降低至45秒)对肝细胞癌(HCC)的诊断效能。结果显示标准1特异度高(93.1%)但敏感度低(52.6%);三种改良标准均显著提高敏感度(分别至68.4%、67.1%、63.2%,均P<.05),且未显著降低特异度或阳性预测值(均P>.05)。结论认为整合AFP或修改早期廓清阈值可显著提高CEUS LR-5诊断NC-HBV患者HCC的敏感度,同时保持高特异度和阳性预测值。

要点

  • 原始CEUS LI-RADS对NC-HBV患者HCC诊断敏感度低(52.6%),特异度93.1%,PPV 95.2%。
  • 将AFP>200 ng/mL的LR-M结节重分类为LR-5可使敏感度提高至68.4%(P<.05)。
  • 将早期廓清阈值从60秒降至45秒可使敏感度提高至63.2%(P<.05)。

核心结论

  • 在NC-HBV患者中,CEUS LR-5对HCC具有高特异度;整合AFP或修改早期廓清阈值可显著提高CEUS LR-5诊断HCC的敏感度,同时保持高特异度和PPV。

研究设计与样本

  • 回顾性分析纳入105例经病理确诊的NC-HBV患者局灶性肝脏病变,比较原始CEUS LI-RADS(标准1)与三种改良标准(标准2、3、4)的诊断效能,以病理为参考标准。

诊断标准与关键数值

  • 标准1(原始CEUS LI-RADS)诊断HCC的敏感度52.6%、特异度93.1%、PPV 95.2%;标准2(AFP>200 ng/mL的LR-M重分类为LR-5)敏感度68.4%;标准3(AFP>400 ng/mL的LR-M重分类为LR-5)敏感度67.1%;标准4(早期廓清阈值从60秒降至45秒)敏感度63.2%;标准2、3、4与标准1相比敏感度均显著提高(均P<.05),特异度及PPV无显著降低(均P>.05);对非HCC恶性肿瘤,标准2、3、4的修订LR-M特异度分别为82.8%、81.6%、82.8%,均高于标准1的69.0%(均P<.01),敏感度无统计学变化(均P>.05)。

临床应用与阅片要点

  • 在NC-HBV患者中应用CEUS LI-RADS时,可考虑将AFP>200 ng/mL或>400 ng/mL的LR-M结节重新分类为LR-5,或将早期廓清阈值从60秒降低至45秒,以提高HCC诊断敏感度(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To improve the diagnostic performance of contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma (HCC) in non-cirrhotic hepatitis B virus (NC-HBV) patients by integrating serum alpha-fetoprotein (AFP) or adjusting washout thresholds.

MATERIALS AND METHODS: A retrospective analysis included 105 pathologically confirmed focal liver lesions in NC-HBV patients. The diagnostic performance of the original CEUS LI-RADS (Criteria 1) was compared with three modified versions: reclassifying LR-M nodules with AFP > 200 ng/mL as LR-5 (Criteria 2), AFP > 400 ng/mL as LR-5 (Criteria 3), and reducing the early washout threshold for LR-M from 60 seconds to 45 seconds (Criteria 4). Sensitivity, specificity, and positive predictive value (PPV) were assessed.

RESULTS: Criteria 1 showed high specificity (93.1%) and PPV (95.2%) but low sensitivity (52.6%) for HCC. Criteria 2, 3, and 4 significantly increased sensitivity to 68.4%, 67.1%, and 63.2%, respectively (all P < .05), without significantly reducing specificity or PPV (all P > .05). For non-HCC malignancies, the specificity of revised LR-M increased to 82.8%, 81.6%, and 82.8% with Criteria 2, 3, and 4, respectively, compared to Criterion 1 (69.0%; all P < .01), while sensitivities remained statistically unchanged (all P > .05).

CONCLUSION: CEUS LR-5 has high specificity for characterising HCC in NC-HBV patients. Integrating AFP or modifying the early washout threshold can significantly improve the sensitivity of CEUS LR-5 for diagnosing HCC in NC-HBV patients, while maintaining high specificity and PPV.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Gong W, Gong S, Chang H, et al. Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria. Clin Radiol. 2026. PMID: 41849926. doi:10.1016/j.crad.2026.107292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。